FIELD: biotechnology.
SUBSTANCE: invention relates to immunogenic conjugates containing a capsular polysaccharide Streptococcus pneumoniae serotype 15B covalently bound to a carrier protein, to methods for their preparation and to immunogenic compositions containing them.
EFFECT: invention can be used for treating diseases associated with the presence of Streptococcus pneumoniae.
21 cl, 1 dwg, 4 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULE SACCHARIDE ANTIGENS AND THEIR USE | 2015 |
|
RU2771293C2 |
STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | 2015 |
|
RU2688831C2 |
CAPSULAR POLYSACCHARIDES OF STREPTOCOCCUS PNEUMONIAE AND THEIR CONJUGATES | 2015 |
|
RU2805417C1 |
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND APPLICATION THEREOF | 2021 |
|
RU2774075C1 |
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES | 2018 |
|
RU2762723C2 |
METHOD OF PRODUCING IMMUNOGENIC CONJUGATE OF CAPSULAR POLYSACCHARIDE STREPTOCOCCUS PNEUMONIAE-CARRIER PROTEIN | 2015 |
|
RU2710393C2 |
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCUS VACCINES | 2016 |
|
RU2712622C2 |
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USE THEREOF | 2015 |
|
RU2687460C2 |
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USE THEREOF | 2015 |
|
RU2778704C2 |
STREPTOCOCCUS PNEUMONIAE CAPSULE POLYSACCHARIDE AND ITS IMMUNOGENIC CONJUGATE | 2019 |
|
RU2803122C2 |
Authors
Dates
2021-02-26—Published
2015-01-15—Filed